QR Kodea

Variation in the Humoral Immune Response Induced by the Administration of the BNT162b2 Pfizer/BioNTech Vaccine: A Systematic Review

The BNT162b2 Pfizer/BioNTech vaccine was the first emergency approved vaccine during the COVID-19 pandemic. The aim of this systematic review was to examine the variations in the humoral immune response induced by the administration of the BNT162b2 vaccine in patients with previous SARS-CoV-2 infect...

Deskribapen osoa

Gorde:
Egile Nagusiak: Karen Cortés-Sarabia, Mayralina Gutiérrez-Torres, Escarlet Maleny Mendoza-Renteria, Marco Antonio Leyva-Vázquez, Amalia Vences-Velázquez, Daniel Hernández-Sotelo, Fredy Omar Beltrán-Anaya, Oscar Del Moral-Hernández, Berenice Illades-Aguiar
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: MDPI AG 2022-06-01
Saila:Vaccines
Gaiak:
BNT162b2
vaccine
SARS-CoV-2
COVID-19
humoral response
comorbidities
Sarrera elektronikoa:https://www.mdpi.com/2076-393X/10/6/909
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak